News Focus
News Focus
Followers 6
Posts 137
Boards Moderated 0
Alias Born 11/27/2018

Re: AVII77 post# 163595

Wednesday, 11/28/2018 3:09:44 PM

Wednesday, November 28, 2018 3:09:44 PM

Post# of 447426
Hi AVII77,

Thanks for the warm welcome, I appreciate it. There are a ton of experts here in the scientific realm, I was just wanting to give back by providing some input from a regulatory perspective; it seems timely, especially as we move towards the regulatory submissions.

Good question regarding the timing of the pre-sNDA meeting, unfortunately not sure I have a great answer there. I have typically seen these meetings happen ~3.5-4 months in advance of submission date, not a full year or so ahead. I'm by no means an expert on Amarin, and their whole backstory here, I just became an investor back in early October. I'll see what else I can learn regarding the pre-sNDA meeting held on 3/7/18, wasn't even aware it had happened.

As for your other question, everything I have seen, indicates an sNDA will be filed. This would be needed for expanded label. That said, a separate submission containing R-IT results could also be filed to the ANCHOR sNDA, or it could just be submitted under the upcoming sNDA, and the ANCHOR sNDA could cross reference it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News